293 related articles for article (PubMed ID: 30442177)
1. Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches.
Fraldi A; Serafini M; Sorrentino NC; Gentner B; Aiuti A; Bernardo ME
Ital J Pediatr; 2018 Nov; 44(Suppl 2):130. PubMed ID: 30442177
[TBL] [Abstract][Full Text] [Related]
2. Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art.
Consiglieri G; Bernardo ME; Brunetti-Pierri N; Aiuti A
Hematol Oncol Clin North Am; 2022 Aug; 36(4):865-878. PubMed ID: 35773049
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology applied to treatment of mucopolysaccharidoses.
Schuh RS; Baldo G; Teixeira HF
Expert Opin Drug Deliv; 2016 Dec; 13(12):1709-1718. PubMed ID: 27322551
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.
Lau AA; Hemsley KM
J Mol Med (Berl); 2017 Oct; 95(10):1043-1052. PubMed ID: 28660346
[TBL] [Abstract][Full Text] [Related]
5. Treatment of brain disease in the mucopolysaccharidoses.
Scarpa M; Orchard PJ; Schulz A; Dickson PI; Haskins ME; Escolar ML; Giugliani R
Mol Genet Metab; 2017 Dec; 122S():25-34. PubMed ID: 29153844
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art.
de Castro MJ; Del Toro M; Giugliani R; Couce ML
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502108
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for Mucopolysaccharidoses.
Sawamoto K; Chen HH; Alméciga-Díaz CJ; Mason RW; Tomatsu S
Mol Genet Metab; 2018 Feb; 123(2):59-68. PubMed ID: 29295764
[TBL] [Abstract][Full Text] [Related]
8. Current and new therapies for mucopolysaccharidoses.
Penon-Portmann M; Blair DR; Harmatz P
Pediatr Neonatol; 2023 Feb; 64 Suppl 1():S10-S17. PubMed ID: 36464587
[TBL] [Abstract][Full Text] [Related]
9. [Principles of therapeutic approaches for mucopolysaccharidoses].
Caillaud C
Arch Pediatr; 2014 Jun; 21 Suppl 1():S39-45. PubMed ID: 25063383
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for neurologic manifestations of mucopolysaccharidoses.
Wolf DA; Banerjee S; Hackett PB; Whitley CB; McIvor RS; Low WC
Expert Opin Drug Deliv; 2015 Feb; 12(2):283-96. PubMed ID: 25510418
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments.
Sawamoto K; Stapleton M; Alméciga-Díaz CJ; Espejo-Mojica AJ; Losada JC; Suarez DA; Tomatsu S
Drugs; 2019 Jul; 79(10):1103-1134. PubMed ID: 31209777
[TBL] [Abstract][Full Text] [Related]
12. Gene delivery strategies for the treatment of mucopolysaccharidoses.
Baldo G; Giugliani R; Matte U
Expert Opin Drug Deliv; 2014 Mar; 11(3):449-59. PubMed ID: 24450877
[TBL] [Abstract][Full Text] [Related]
13. Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses.
Pan D
Curr Pharm Biotechnol; 2011 Jun; 12(6):884-96. PubMed ID: 21235445
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs for the treatment of mucopolysaccharidoses.
Giugliani R; Federhen A; Vairo F; Vanzella C; Pasqualim G; da Silva LM; Giugliani L; de Boer AP; de Souza CF; Matte U; Baldo G
Expert Opin Emerg Drugs; 2016; 21(1):9-26. PubMed ID: 26751109
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.
Peck SH; Casal ML; Malhotra NR; Ficicioglu C; Smith LJ
Mol Genet Metab; 2016 Aug; 118(4):232-43. PubMed ID: 27296532
[TBL] [Abstract][Full Text] [Related]
16. Gene therapies for mucopolysaccharidoses.
Rossi A; Brunetti-Pierri N
J Inherit Metab Dis; 2024 Jan; 47(1):135-144. PubMed ID: 37204267
[TBL] [Abstract][Full Text] [Related]
17. Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.
Banecka-Majkutewicz Z; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Węgrzyn A; Węgrzyn G
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):461-8. PubMed ID: 22949095
[TBL] [Abstract][Full Text] [Related]
18. Current and potential therapeutic strategies for mucopolysaccharidoses.
Noh H; Lee JI
J Clin Pharm Ther; 2014 Jun; 39(3):215-24. PubMed ID: 24612142
[TBL] [Abstract][Full Text] [Related]
19. Current and Emerging Therapies for Mucopolysaccharidoses.
Lagler FB
Handb Exp Pharmacol; 2020; 261():39-56. PubMed ID: 31451968
[TBL] [Abstract][Full Text] [Related]
20. Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets.
Leal AF; Benincore-Flórez E; Rintz E; Herreño-Pachón AM; Celik B; Ago Y; Alméciga-Díaz CJ; Tomatsu S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
